Related Experiment Videos
Protein microarrays: a new tool for profiling antibody cross-reactivity
Paul F Predki1, Dawn Mattoon, Rhonda Bangham
1Invitrogen Protein Microarray Center, 688 E Main St, Branford, CT 06405, USA. paul.predki@invitrogen.com
Human Antibodies
|January 21, 2006
Summary
Antibody cross-reactivity can hinder research and drug development. Protein microarrays offer a powerful new method for quickly assessing antibody specificity against thousands of proteins.
Area of Science:
- Biochemistry
- Immunology
- Proteomics
Background:
- Antibody cross-reactivity complicates experimental results and impedes therapeutic antibody development.
- Traditional methods like immunohistochemistry and Western analysis have limitations in fully assessing antibody specificity.
Purpose of the Study:
- To review antibody cross-reactivity examples and characterization methods.
- To highlight the utility of protein microarrays for assessing antibody specificity.
Main Methods:
- Review of reported antibody cross-reactivity cases.
- Analysis of standard techniques for antibody specificity assessment.
- Evaluation of protein microarray technology for high-throughput specificity screening.
Main Results:
- Antibody cross-reactivity is a significant challenge in biological research and biotherapeutics.
- Protein microarrays enable rapid, large-scale characterization of antibody specificity.
- This technology addresses limitations of conventional methods.
Conclusions:
- Protein microarrays represent a significant advancement in evaluating antibody specificity.
- Their application is crucial for reliable experimental interpretation and successful therapeutic antibody development.